Marc Schmitz Selected Research

Ligands

11/2021	AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant Leukemia.
9/2021	A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer.
3/2006	Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Schmitz Research Topics

Disease

65	Neoplasms (Cancer) 05/2024 - 08/2002
10	Leukemia 01/2024 - 11/2005
10	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 04/2009
10	Prostatic Neoplasms (Prostate Cancer) 05/2017 - 12/2002
9	Melanoma (Melanoma, Malignant) 04/2024 - 05/2005
7	Carcinoma (Carcinomatosis) 05/2024 - 09/2003
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 06/2003
6	Wilms Tumor (Wilm's Tumor) 01/2024 - 11/2016
6	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 06/2003
4	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2017 - 03/2011
3	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 09/2022
3	Breast Neoplasms (Breast Cancer) 01/2023 - 04/2004
3	Neoplasm Metastasis (Metastasis) 12/2022 - 06/2011
3	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2005
3	Glioma (Gliomas) 01/2007 - 01/2005
2	Adenocarcinoma 01/2024 - 04/2023
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 09/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2023 - 11/2022
2	Transitional Cell Carcinoma 01/2023 - 01/2022
2	Infections 01/2022 - 06/2012
2	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2007
2	Lymphoma (Lymphomas) 01/2011 - 06/2003
1	Esophageal Neoplasms (Esophageal Cancer) 05/2024
1	Clear-cell metastatic renal cell carcinoma 11/2023
1	Colitis 11/2023
1	Bites and Stings (Sting) 01/2023
1	Hyperthermia 01/2023

Drug/Important Bio-Agent (IBA)

25	AntigensIBA 12/2023 - 12/2002
19	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2003
12	Peptides (Polypeptides)IBA 12/2021 - 12/2002
10	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2010
9	CytokinesIBA 04/2024 - 01/2010
8	AntibodiesIBA 01/2020 - 01/2007
7	Immune Checkpoint InhibitorsIBA 12/2022 - 03/2018
7	SurvivinIBA 01/2018 - 06/2003
5	NivolumabIBA 05/2024 - 01/2020
5	Programmed Cell Death 1 ReceptorIBA 09/2021 - 03/2018
4	IpilimumabIBA 05/2024 - 01/2020
4	RNA (Ribonucleic Acid)IBA 04/2024 - 06/2003
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 08/2002
4	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2021 - 03/2011
4	VaccinesIBA 01/2020 - 01/2010
3	Neoplasm Antigens (Tumor Antigens)IBA 04/2024 - 04/2008
3	LigandsIBA 11/2021 - 03/2006
3	EpitopesIBA 01/2019 - 12/2002
3	SteroidsIBA 02/2016 - 04/2009
3	Bispecific AntibodiesIBA 09/2012 - 06/2011
3	Inhibitor of Apoptosis ProteinsIBA 07/2007 - 01/2007
3	HLA-A*02:01 antigenIBA 06/2006 - 12/2002
3	Messenger RNA (mRNA)IBA 04/2004 - 07/2003
2	PlatinumIBA 05/2024 - 01/2023
2	IgG Receptors (Fc gamma RI)IBA 04/2024 - 08/2002
2	Interleukin-2 (IL2)IBA 01/2024 - 11/2022
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 10/2018
2	Nucleic AcidsIBA 01/2023 - 03/2011
2	Interleukin-10 (Interleukin 10)IBA 11/2022 - 06/2015
2	cyclopropapyrroloindoleIBA 09/2022 - 01/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2021 - 01/2011
2	Granzymes (Granzyme)IBA 01/2021 - 01/2019
2	pembrolizumabIBA 01/2020 - 12/2018
2	B7-H1 AntigenIBA 09/2019 - 03/2018
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019 - 02/2013
2	Lenalidomide (CC 5013)FDA Link 11/2013 - 10/2012
2	AndrogensIBA 06/2011 - 09/2005
2	HLA Antigens (Human Leukocyte Antigens)IBA 11/2007 - 01/2007
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2007 - 09/2003
2	SOXC Transcription FactorsIBA 01/2007 - 01/2005
2	Complementary DNA (cDNA)IBA 09/2004 - 04/2004
1	ParaffinIBA 05/2024
1	GoldIBA 05/2024
1	Formaldehyde (Formol)FDA Link 05/2024
1	RNA Splicing FactorsIBA 04/2024
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2024
1	Radioisotopes (Radionuclides)IBA 12/2023
1	Chelating AgentsIBA 12/2023
1	binimetinibIBA 12/2023
1	cobimetinibIBA 12/2023
1	Mitogen-Activated Protein KinasesIBA 12/2023
1	dabrafenibIBA 12/2023
1	trametinibIBA 12/2023
1	VemurafenibIBA 12/2023
1	encorafenibIBA 12/2023
1	temsirolimus FDA Link 11/2023
1	Lipase (Acid Lipase)FDA Link 11/2023
1	A-Form DNA (A-DNA)IBA 01/2023
1	InterferonsIBA 01/2023
1	EnzymesIBA 01/2023
1	Estrogen ReceptorsIBA 01/2023

Therapy/Procedure

29	Immunotherapy 01/2024 - 09/2002
25	Therapeutics 05/2024 - 12/2002
7	Drug Therapy (Chemotherapy) 05/2024 - 11/2005
5	Stem Cell Transplantation 11/2016 - 11/2005
5	Hematopoietic Stem Cell Transplantation 11/2016 - 11/2005
4	Cell Transplantation 01/2022 - 06/2011
3	Radiotherapy 05/2024 - 01/2020
3	Neoadjuvant Therapy 01/2024 - 11/2022
2	Chemoradiotherapy 05/2024 - 01/2019
2	Transplantation 01/2020 - 10/2017
2	Precision Medicine 01/2019 - 05/2018
1	Ligation 04/2023